Semaglutide / GLP-1 Therapy

What Semaglutide and GLP-1 Therapy Are

If you have been looking into options for weight and metabolic health, you have probably come across semaglutide. Semaglutide is a GLP-1 receptor agonist, a class of medications that mimic glucagon-like peptide-1, a hormone the gut naturally releases after eating. It was first developed to treat type 2 diabetes, and the class is now widely used for chronic weight management and metabolic health. Semaglutide is given as a once-weekly injection under the skin, and a related oral form exists. Other medications in or near this class include liraglutide (a daily GLP-1 agonist) and tirzepatide (a dual GIP/GLP-1 receptor agonist).

At ENNU Life, GLP-1 therapy is used as one tool within a broader metabolic and longevity program, not as a standalone fix. It works best when paired with nutrition, resistance training, sleep optimization, and ongoing clinical monitoring.

How GLP-1 Therapy Works

GLP-1 receptor agonists work through several well-established mechanisms:

• Appetite regulation: They act on receptors in the brain (including the hypothalamus) that govern fullness and hunger, which reduces appetite and food intake.
• Slowed gastric emptying: Food leaves the stomach more slowly, so you feel full longer after meals.
• Glucose-dependent insulin secretion: They prompt the pancreas to release insulin when blood glucose is elevated, and they suppress glucagon. This improves blood sugar control with a low built-in risk of low blood sugar (hypoglycemia) when used alone.

For most patients, the result is lower calorie intake, better blood sugar control, and meaningful weight loss over months of consistent use.

Who May Be a Candidate

GLP-1 therapy is generally considered for adults managing weight and metabolic health, especially those with:

• Obesity, or overweight status with a weight-related condition such as type 2 diabetes, prediabetes, high blood pressure (hypertension), or abnormal cholesterol (dyslipidemia)
• Difficulty reaching lasting weight loss through diet and exercise alone
• Metabolic markers a clinician wants to improve, checked through bloodwork such as fasting glucose, HbA1c, and a lipid panel

A licensed clinician decides whether you are a candidate based on your full medical history, current medications, and lab results. GLP-1 therapy is not appropriate for everyone. It is generally avoided in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and it is not used during pregnancy. A history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or certain eating disorders calls for careful clinical evaluation before starting.

What Treatment and Optimization Look Like

GLP-1 therapy usually starts at a low dose and increases gradually over several weeks. This dose titration is intentional: it gives the body time to adjust and helps limit gastrointestinal side effects. The maintenance dose is set for you based on how you respond and how well you tolerate it.

A well-run program focuses on more than the number on the scale:

• Protein intake and resistance training to protect lean muscle mass during weight loss
• Periodic lab monitoring of metabolic markers to confirm the therapy is improving your underlying health
• Regular clinical follow-up to adjust dosing, manage side effects, and reassess goals
• A long-term plan, since weight regain is common after stopping; your clinician should discuss a maintenance strategy from the start

Side Effects and Safety Considerations

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. They tend to be most noticeable when you start therapy or raise the dose. They often ease over time and can be reduced with slower titration, smaller meals, and enough hydration. Less common but important risks discussed in this medication class include pancreatitis, gallbladder problems, and dehydration-related effects. Anyone with severe or lasting abdominal pain should seek prompt medical evaluation. Your clinician will review your complete medication list, because GLP-1 therapy can affect how other drugs are absorbed and dosed.

Next Steps

If you are considering GLP-1 therapy for weight management or metabolic health, the right first step is a clinical evaluation that reviews your history, goals, and bloodwork so a licensed provider can determine whether this treatment fits you.

Start your ENNU Life health assessment

Educational only, not medical advice; consult a licensed clinician. This page does not establish a patient-provider relationship, and treatment decisions, dosing, and candidacy must be individualized by a licensed clinician who has evaluated your complete medical history.